Role of nitric oxide in vascular tone and in reactivity to isoproterenol and adenosine in the goat coronary circulation

European Journal of Pharmacology

Volumn 387, Issue 1, 2000, Pages 93-99

  Fernández, Nuria ^a   Sánchez, Miguel Angel ^a   Martínez, María Angeles ^a   García Villalón, Angel Luis ^a   Monge, Luis ^a   Gómez, Bernardino ^a   Diéguez, Godofredo ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

Adrenoceptor stimulation; Coronary blood flow; Coronary vasodilatation; Coronary vasodilator tone

Indexed keywords

ACETYLCHOLINE; ADENOSINE; ARGININE; BETA ADRENERGIC RECEPTOR; ISOPRENALINE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD VESSEL TONE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DILATATION; FEMALE; GOAT; HEMODYNAMICS; NONHUMAN; PRIORITY JOURNAL;

ACETYLCHOLINE; ADENOSINE; ADRENERGIC BETA-AGONISTS; ANIMALS; ARGININE; BLOOD PRESSURE; CORONARY CIRCULATION; CORONARY VESSELS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; GOATS; HEART RATE; INJECTIONS, INTRAVENOUS; ISOPROTERENOL; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; VASCULAR RESISTANCE; VASODILATION; VASODILATOR AGENTS;

EID: 0342948734     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00766-9     Document Type: Article

References (34)

1. Abebe W., Makujina S.R., Mustafa S.J. Adenosine receptor-mediated relaxation of porcine coronary artery in presence and absence of endothelium. Am. J. Physiol. 266:1994;H2018-H2025.
2. Bassenge E. Control of coronary blood flow by autacoids. Basic Res. Cardiol. 90:1995;125-141.
3. Bauersachs J., Hecker M., Busse R. Display of the characteristics of endothelium-derived hyperpolarization factor by a cytochrome P450-derived arachidonic acid metabolite in the coronary microcirculation. Br. J. Pharmacol. 113:1994;1548-1553.
4. Béa M.L., Ghaleh B., Giudicelli J.F., Berdeaux A. Lack of importance of NO in β-adrenoceptor-mediated relaxation of large epicardial canine coronary arteries. Br. J. Pharmacol. 111:1994;981-982.
5. Bolotina V.M., Najibi S., Palacino J.J., Pagano P.J., Cohen R.A. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature. 368:1994;850-853.
6. Brown W.E., Magno M.G., Buckman P.D., Meo F.D., Gale D.R., Mannion J.D. The coronary collateral circulation in normal goats. J. Surg. Res. 51:1991;54-59.
7. G-nitro L-arginine methyl ester and other alkyl esters of arginine are muscarinic receptor antagonists. Circ. Res. 72:1993;387-395.
8. Canty J.M. Jr., Schwartz J.S. Nitric oxide mediates flow-dependent epicardial coronary vasodilation to changes in pulse frequency but not mean flow in conscious dogs. Circulation. 89:1994;375-384.
9. Chu A., Chambers D.E., Lin C.C., Kuehl W.D., Palmer R.M.J., Moncada S., Cobb F.R. Effects of inhibition of nitric oxide formation on basal vasomotion and endothelium-dependent responses of the coronary arteries in awake dogs. J. Clin. Invest. 87:1991;1964-1968.
10. Crystal G.J., Zhou X., Gurevicius J., Ramez Salem M. Influence of nitric oxide on vascular, metabolic, and contractile responses to dobutamine in situ canine hearts. Anesth. Analg. 87:1998;994-1001.
11. Davis C.A. III, Sherman A.J., Yaroshenko Y., Harris K.R., Hedjbeli S., Parker M.A., Klocke F.J. Coronary vascular responsiveness to adenosine is impaired additively by blockade of nitric oxide synthesis and a sulfonylurea. J. Am. Coll. Cardiol. 31:1998;816-822.
12. Feigl E.O. Coronary physiology. Physiol. Rev. 63:1983;1-205.
13. Feletou M., Vanhoutte P.M. Endothelium-dependent hyperpolarization of canine coronary smooth muscle. Br. J. Pharmacol. 93:1988;515-524.
14. García J.L., Fernández N., García-Villalón A.L., Monge L., Gómez B., Diéguez G. Effects of nitric oxide synthesis inhibition on the goat coronary circulation under basal conditions and after vasodilator stimulation. Br. J. Pharmacol. 106:1992;563-567.
15. Harder D.R., Belardinelli L., Sperelakis H., Rubio R., Berne R.M. Differential effects of adenosine and nitroglycerin on the action potentials of large and small coronary arteries. Circ. Res. 44:1979;176-188.
16. Hodgson J.McB., Marshall J.J. Direct vasoconstriction and endothelium-dependent vasodilation. Mechanisms of acetylcholine effects on coronary flow and arterial diameter in patients with nonstenotic coronary arteries. Circulation. 79:1989;1043-1051.
17. Kaneko H., Endo T., Kiuchi K., Hayakawa H. Inhibition of nitric oxide synthesis reduces coronary blood flow response but does not increase cardiac contractile response to β-adrenergic stimulation in normal dogs. J. Cardiovasc. Pharmacol. 27:1996;247-254.
18. Kirkebøen K.A., Naess P.A., Offstad J., Ilebekk A. Effects of regional inhibition of nitric oxide synthesis in intact porcine hearts. Am. J. Physiol. 266:1994;H1516-H1527.
19. Kuo L., Davis M.J., Chilian W.M. Endothelium-dependent, flow-induced dilation of isolated coronary arterioles. Am. J. Physiol. 259:1990;H1063-H1110.
20. Lautt W.W. Resistance or conductance for expression of arterial vascular tone. Microvasc. Res. 37:1989;230-236.
21. Matsunaga T., Okumura K., Tsunoda R., Tayama S., Tabuchi T., Yasue H. Role of adenosine in regulation of coronary flow in dogs with inhibited syntesis of endothelium-derived nitric oxide. Am. J. Physiol. 270:1996;H427-H434.
22. Ming Z., Parent R., Lavallée M. Nitric oxide-independent dilation of conductance coronary arteries to acetylcholine in conscious dogs. Circ. Res. 81:1997;977-987.
23. + channels (BK(Ca)) in smooth muscle cells isolated from the rat mesenteric artery. Br. J. Pharmacol. 124:1998;1131-1140.
24. Moncada S., Palmer R.M.J., Higgs E.A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 43:1991;109-142.
25. Olsson R.A., Pearson J.D. Cardiovascular purinoceptors. Physiol. Rev. 70:1990;761-845.
26. Parent R., Paré R., Lavallée M. Contribution of nitric oxide to dilation of resistance coronary vessels in conscious dogs. Am. J. Physiol. 262:1992;H10-H16.
27. Parent R., Al-Obaidi M., Lavallée M. Nitric oxide formation contributes to β-adrenergic dilation of resistance coronary vessels in conscious dogs. Circ. Res. 73:1993;241-251.
28. Quillen J.E., Harrison D.G. Vasomotor properties of porcine endocardial and epicardial microvessels. Am. J. Physiol. 262:1992;H1143-H1148.
29. Quyyumi A.A., Dakak N., Andrews N.P., Husain S., Arora S., Gilligan D.M., Panza J.A., Cannon R.O. III Nitric oxide activity in the human coronary circulation: impact of risk factors for coronary atherosclerosis. J. Clin. Invest. 95:1995;1747-1755.
30. Quyyumi A.A., Dakak N., Diodati J.G., Gilligan D.M., Panza J.A., Cannon R.O. Effect of L-arginine on human coronary endothelium-dependent and physiologic vasodilation. J. Am. Coll. Cardiol. 30:1997;1220-1227.
31. Rubanyi G., Vanhoutte P.M. Endothelium-removal decreases relaxations of canine coronary arteries caused by β-adrenergic agonists and adenosine. J. Cardiovasc. Pharmacol. 7:1985;139-144.
32. Shiode N., Morishima N., Nakayama K., Tamagata T., Matsuura H., Kajiyama G. Flow-mediated vasodilation of human epicardial coronary arteries: effects of inhibition of nitric oxide synthesis. J. Am. Coll. Cardiol. 27:1996;304-310.
33. Tayama S., Okumura K., Matsunaga T., Tsunoda R., Tabuchi T., Iwasa A., Yasue H. Influence of chronic nitric oxide inhibition of coronary blood flow regulation: a study of the role of endogenous adenosine in anesthetized, open-chested dogs. Jpn. Circ. J. 62:1998;371-378.
34. Van Winkle D.M., Feigl E.O. Acetylcholine causes coronary vasodilation in dogs and baboons. Circ. Res. 65:1989;1580-1593.